AXSYM, AUSAB

FDA Premarket Approval P060003

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the axsym ausab assay. The device is indicated for: axsym ausab reagent pack is a microparticle enzyme immunoassay (meia) intended for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in adult and pediatric serum (including serum collected in serum separator tubes) or plasma (collected in sodium heparin). The assay is used for the quantitative measurement of antibody response to hepatitis b virus (hbv) vaccination for the determination of hbv immune status, and for the diagnosis of hbv disease associated with hbv infection when used in conjunction with other laboratory results and clinical information. The axsym ausab standard calibrators are used for the calibration of the axsym system when the system is used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the axsym ausab reagent pack. The performance of the axsym ausab standard calibrators has not been established with any other anti-hbs assays. The axsym ausab controls are used for monitoring the performance of the axsym system (reagent, calibrators, and instrument) when used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) when using the axsym ausab reagent pack. The performance of the axsym ausab controls has not been established with any other anti-hbs assays.

DeviceAXSYM, AUSAB
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantABBOTT LABORATORIES INC
Date Received2006-02-10
Decision Date2006-08-07
Notice Date2007-04-30
PMAP060003
SupplementS
Product CodeLOM 
Docket Number07M-0161
Advisory CommitteeMicrobiology
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT LABORATORIES INC 100 Abbott Park Road dept 9va- Ap5-2 abbott Park, IL 60064
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P060003Original Filing
S012 2012-11-13 30-day Notice
S011 2011-11-02 135 Review Track For 30-day Notice
S010 2011-09-06 30-day Notice
S009 2011-03-21 135 Review Track For 30-day Notice
S008 2011-01-31 Normal 180 Day Track No User Fee
S007 2010-11-01 Normal 180 Day Track No User Fee
S006 2010-09-27 30-day Notice
S005 2010-06-11 Real-time Process
S004 2009-02-17 30-day Notice
S003 2007-01-17 30-day Notice
S002 2006-09-05 30-day Notice
S001 2006-08-15 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.